Euroapi S.A. (OTCMKTS:EAPIF – Get Free Report) saw a significant increase in short interest in October. As of October 15th, there was short interest totaling 28,026 shares, an increase of 63.3% from the September 30th total of 17,158 shares. Based on an average trading volume of 549 shares, the days-to-cover ratio is currently 51.0 days.
Euroapi Price Performance
Shares of OTCMKTS:EAPIF opened at C$0.89 on Tuesday. Euroapi has a 12-month low of C$0.84 and a 12-month high of C$3.46. The business has a 50 day moving average of C$0.99 and a two-hundred day moving average of C$1.52.
About Euroapi
EUROAPI is a France-based pharmaceutical company that develops, manufactures and markets active pharmaceutical ingredients (APIs), the substances responsible for the therapeutic effects of medicines. The company supplies APIs for use in a range of prescription and over-the-counter medicines, serving pharmaceutical companies and other healthcare customers.
Its portfolio includes chemical and biological APIs, as well as specialized products such as peptides and complex molecules. EUROAPI also provides contract development and manufacturing services, supporting customers from process development and scale-up through commercial production and regulatory supply.
EUROAPI was established in 2022 through the separation and listing of Sanofi’s API business.
Recommended Stories
- Five stocks we like better than Euroapi
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for Euroapi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Euroapi and related companies with MarketBeat.com's FREE daily email newsletter.
